Northwest Biotherapeutics | NWBO - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Northwest Biotherapeutics

Northwest Biotherapeutics reported $-14372000 in Operating Profit for its fiscal quarter ending in March of 2023.


Operating Profit Change
Agenus AGEN:US USD -54341000 5.35M
AstraZeneca AZN:LN USD 2.55B 1.46B
Bristol-Myers Squibb BMY:US USD 3.1B 1.15B
Celldex Therapeutics CLDX:US USD -32471000 4.59M
CTI Biopharma CTIC:US USD -9232000 4.36M
Eisai 4523:JP JPY 26.22B 17.65B
Infinity Pharmaceuticals INFI:US USD -11507000 1.97M
Merck & Co MRK:US USD 3.72B 286M
Mirati Therapeutics MRTX:US USD -193823000 17.9M
Northwest Biotherapeutics NWBO:US USD -14372000 6.34M
Pfizer PFE:US USD 6.79B 1.62B
Plus Therapeutics, Inc. CYTX:US USD -4720000 852K
Roche Holding ROG:VX CHF 5.93B 5.62B